DR. CATHERINE SEWELL, M.D.
Medical Practice at Wolfe St, Baltimore, MD

License number
Maryland MD-073323-L
Category
Medical Practice
Type
Obstetrics & Gynecology
License number
Maryland D53302
Category
Medical Practice
Type
Obstetrics & Gynecology
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 614-4496

Organization information

See more information about CATHERINE SEWELL at bizstanding.com

Catherine A Sewell MD

600 N Wolfe St, Baltimore, MD 21287

Industry:
Obgyn
Doing business as:
Catherine Sewell MD
Phone:
(410) 955-5000 (Phone)
Catherine Angela Sewell
Categories:
Physicians & Surgeons

Professional information

Catherine Sewell Photo 1

Dr. Catherine Sewell, Baltimore MD - MD (Doctor of Medicine)

Specialties:
Obstetrics & Gynecology
Address:
600 N Wolfe St, Baltimore 21287
10755 Falls Rd STE 420, Lutherville 21093
(410) 583-2749 (Phone), (410) 583-2756 (Fax)
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
(410) 955-3071 (Phone), (410) 955-1464 (Fax)
Certifications:
Obstetrics & Gynecology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
600 N Wolfe St, Baltimore 21287
10755 Falls Rd STE 420, Lutherville 21093
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
Greater Baltimore Medical Center
6701 North Charles Street Ave, Towson 21204
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Education:
Medical School
UNIVERSITY OF PENNSYLVANIA / SCHOOL OF MEDICINE
The Johns Hopkins Hospital


Catherine Sewell Photo 2

Compositions Comprising Angiogenic Factors And Methods Of Use Thereof

US Patent:
2012011, May 10, 2012
Filed:
Mar 4, 2010
Appl. No.:
13/254607
Inventors:
Matthew Seavey - Secane PA, US
Yvonne Paterson - Philadelphia PA, US
Paulo Maciag - Robbinsville NJ, US
Duane Sewell - Baltimore MD, US
Catherine Sewell - Baltimore MD, US
International Classification:
A61K 39/02, A61P 35/00, C12N 1/21, A61P 37/04
US Classification:
4241901, 42419711, 4242341, 4352523
Abstract:
The present invention provides recombinant strains comprising an angiogenic factor, recombinant polypeptides comprising an angiogenic factor operatively linked to a polypeptide comprising a PEST-like sequence, recombinant nucleotide molecules encoding same, related vaccines, and immunogenic and therapeutic methods utilizing same.